Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pharming Group (PHAR)
NASDAQ:PHAR
Holding PHAR?
Track your performance easily
PHAR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.65 - $13.20
Previous Close$8.98
Volume7.31K
Average Volume (3M)7.04K
Market Cap
$617.16M
Enterprise Value$575.28M
Total Cash (Recent Filing)$213.42M
Total Debt (Recent Filing)$171.54M
Price to Earnings (P/E)―
Beta0.78
Next Earnings
Mar 13, 2025EPS Estimate
$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding67,107,324
10 Day Avg. Volume8,710
30 Day Avg. Volume7,043
Standard Deviation0.13
R-Squared0.00027
Alpha-0.00860
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)2.75
Price to Sales (P/S)2.46
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.51
Enterprise Value/Gross Profit2.61
Enterprise Value/Ebitda16.22
Forecast
1Y Price Target
$27.00Price Target Upside203.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Pharming Group News
PremiumPre-Earnings
Is PHAR a Buy, Before Earnings?PremiumCompany Announcements
Pharming Group Delays Leniolisib EU ApprovalOwnership Overview
―
Insiders
<0.01% Mutual Funds
0.06% Other Institutional Investors
99.94% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PHAR FAQ
What was Pharming Group’s price range in the past 12 months?
Pharming Group lowest stock price was $6.65 and its highest was $13.20 in the past 12 months.
What is Pharming Group’s market cap?
Currently, no data Available
When is Pharming Group’s upcoming earnings report date?
Pharming Group’s upcoming earnings report date is Mar 13, 2025 which is in 80 days.
How were Pharming Group’s earnings last quarter?
Pharming Group released its earnings results on Oct 24, 2024. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of -$0.002 by -$0.018.
Is Pharming Group overvalued?
According to Wall Street analysts Pharming Group’s price is currently Undervalued.
Does Pharming Group pay dividends?
Pharming Group does not currently pay dividends.
What is Pharming Group’s EPS estimate?
Pharming Group’s EPS estimate is $0.02.
How many shares outstanding does Pharming Group have?
Pharming Group has 67,835,434 shares outstanding.
What happened to Pharming Group’s price movement after its last earnings report?
Pharming Group reported an EPS of -$0.02 in its last earnings report, missing expectations of -$0.002. Following the earnings report the stock price went down -7.366%.
Which hedge fund is a major shareholder of Pharming Group?
Currently, no hedge funds are holding shares in PHAR
---
Pharming Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$27.00 (203.71% Upside)
$27.00 (203.71% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 9.3%
Last 30 Days ▼ 9.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.20%
12-Months-Change
Fundamentals
Return on Equity
-7.98%
Trailing 12-Months
Asset Growth
-2.51%
Trailing 12-Months
Company Description
Pharming Group
Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on the development and production of human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. Most of the revenue generated from the United States.
---
PHAR Company Deck
---
PHAR Earnings Call
Q3 2024
0:00 / 0:00
---
PHAR Stock 12 Month Forecast
Average Price Target
$27.00
▲(203.71% Upside)
Technical Analysis
Best Analysts Covering PHAR
1 Year
1 Year Success Rate
3/12 ratings generated profit
1 Year Average Return
-12.37%
reiterated a buy rating 7 days ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -12.37% per trade.
---